SAN DIEGO, Oct. 22, 2024 (GLOBE NEWSWIRE) -- (Nasdaq: ARTV), a clinical-stage biotechnology company whose mission is to ...

SFA Therapeutics, Inc., a clinical-stage biopharmaceutical company developing oral small-molecule biosynthetic compounds for ...

Rat LD50 values were taken from the Registry of Toxic Effects of Chemical Substances (RTECS) database [55] and cytotoxicity values were taken from the public National Cancer Institute (NCI ...

MacroGenics, Inc. (NASDAQ: MGNX), a biopharmaceutical company focused on discovering, developing, manufacturing and ...

Antibodies show promise as candidates for therapeutics as well as tools for advancing mechanistic studies of the HER family receptors.

A study set to be published in the journal Archives of Oral Biology in January 2025 explores the potential biological effects ...

Astellas Pharma today announced that the US Food and Drug Administration (FDA) has approved VYLOY (zolbetuximab-clzb) in ...

Researchers identified Janus kinase inhibitors as a promising treatment for the severe drug-induced skin condition toxic ...

Mesoporous silica nanoparticles (MSNs) have a total diameter below 1 µm and pores ranging from 2 to 50 nm in diameter. They ...